Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APACOL: Adapted Physical Activity in Metastatic Colorectal Cancer
NCT06944548Phase 2Not yet recruiting
- Sponsor
- Centre Georges-François Leclerc
- Start
- Jun 2025
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (4 arms), sponsored by Centre Georges-François Leclerc. Primary endpoint: Concentration of complex lipids at 8 weeks. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06944548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06944548.